IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,254 | -23.4% | 5,265 | -11.5% | 0.17% | -21.3% |
| Q2 2023 | $356,702 | +38.0% | 5,949 | +13.8% | 0.21% | +48.6% |
| Q1 2023 | $258,423 | -11.7% | 5,227 | +1.9% | 0.14% | -7.2% |
| Q4 2022 | $292,826 | -27.7% | 5,131 | -40.6% | 0.15% | -5.0% |
| Q3 2022 | $405,000 | +27.4% | 8,638 | +1.5% | 0.16% | +36.4% |
| Q2 2022 | $318,000 | +103.8% | 8,513 | +63.2% | 0.12% | +68.6% |
| Q1 2022 | $156,000 | -17.5% | 5,216 | -5.6% | 0.07% | -1.4% |
| Q4 2021 | $189,000 | -5.0% | 5,523 | +3.1% | 0.07% | -19.3% |
| Q3 2021 | $199,000 | -9.5% | 5,359 | -4.9% | 0.09% | -2.2% |
| Q2 2021 | $220,000 | – | 5,634 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |